BackVyant Bio Overview

Vyant Bio Total Liabilities

Vyant Bio's total liabilities is $5.3M.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$5.30M
16.55% YoYΔ $-1.05M vs prior year quarter

Peer trimmed avg / median

Loading

Vyant Bio Total Liabilities History

Loading

Vyant Bio vs. peers: Total Liabilities Comparison

Loading

Vyant Bio Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Vyant Bio (VYNT) FAQ

As of the most recent data (December 2022), VYNT shows a total liabilities of $5.3M. That compares with $6.3M in the prior-year period — down 16.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, VYNT's total liabilities is now $5.3M (was $6.3M) — a 16.5% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Vyant Bio is outperforming or lagging.

Tracking VYNT's total liabilities over time shows whether Vyant Bio is scaling, shrinking, or reshaping that part of the business. The current reading is $5.3M That compares with $6.3M in the prior-year period — down 16.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has Vyant Bio's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $5.3M) with ownership activity and broader fundamentals.

Vyant Bio's total liabilities is $5.3M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.